Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone for Anxiety in Bipolar Disorder
NCT00374543Phase 4Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Feb 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in generalized anxiety disorder (GAD) comparing Ziprasidone with Placebo (2 arms). Primary endpoint: Hamilton Anxiety Rating Scale at 8 weeks. Started Feb 2006; status: terminated.
02
Drugs
ziprasidone
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00374543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374543.